{"text": ["Bristol-Myers", "Squibb", "Company", "--", "Moody's:", "China's", "rising", "demand", "for", "drugs", "will", "fuel", "foreign", "pharma", "companies'", "growth", "into", "2023"], "created_at": "2019-09-24 15:46:12"}
{"text": ["Pfizer", "Declares", "Fourth-Quarter", "2019", "Dividend"], "created_at": "2019-09-24 14:19:00"}
{"text": ["Exact", "Sciences", "Gets", "FDA", "Nod", "for", "Label", "Expansion", "of", "Cologuard"], "created_at": "2019-09-24 13:10:01"}
{"text": ["Pfizer", "Presents", "New", "Evidence", "of", "IBRANCE\u00ae", "(palbociclib)", "Effectiveness", "in", "HR+,", "HER2-", "Metastatic", "Breast", "Cancer", "Patients", "in", "Four", "Real-World", "Studies", "at", "ESMO", "Congress", "2019"], "created_at": "2019-09-24 12:00:00"}
{"text": ["European", "biotech", "firm", "BioNtech", "plans", "to", "raise", "nearly", "$304", "mln", "in", "U.S.", "IPO"], "created_at": "2019-09-24 11:40:11"}
{"text": ["LabCentral", "co-founder", "issues", "\u2018call", "to", "action'", "to", "biotechs", "on", "drug", "pricing"], "created_at": "2019-09-24 10:34:48"}
